Tscan Therapeutics Inc is trading 5.6% down today at $0.90 as the stock experiences normal volatility and a giveback of recent gains.
- The decline follows a bounce on June 15, 2026, which was fueled by a broad risk-on rally following a tentative U.S.–Iran peace deal.
- No new company-specific announcements or analyst actions have emerged to drive today's price action.
- Broader market indices are currently trading modestly mixed, suggesting the move is likely a correction from previous highs rather than a reaction to new news.